MEDINDIA
English
हिन्दी
Español
français
中文
A haploidentical bone marrow transplant is a form of bone marrow transplant, where the doctors prefer a 50% match between the patient and donor.
Scientists Make New Progress in Bone Marrow Transplant
Australian research institutes are set to change international practice for the treatment of leukaemia patients undergoing bone marrow transplants.
Australian research institutes are set to change international practice for the treatment of leukaemia patients undergoing bone marrow transplants.
TOP INSIGHT
A two-year-old baby with leukemia undergoes first half-match bone marrow transplant in Rajasthan.
Haploidentical bone marrow transplant is a form of bone marrow transplant, where the doctors prefer a close match of HLA (human leukocyte antigen) markers between the patient and donor. Though getting a 100% match is tough, HBLT requires only a 50% match between the patient's HLA markers and donor's.
The baby’s father donated his stem cells as he was found to have a 50 percent match. The surgery was performed in June last year and the baby has recovered well.
Low Intensity Bone Marrow Transplantation Looks Promising for Adults With Sickle Cell Disease
A new study has found that use of low intensity bone marrow transplantation method shows promising results in patients with sickle cell disease
A new study has found that use of low intensity bone marrow transplantation method shows promising results in patients with sickle cell disease
New Drug for Blood Cancer Enters Phase II Clinical Trials
The drug coaxes dormant cancer stem cells to begin differentiating and exit into the blood stream where they can be destroyed by chemotherapy agents.
The drug coaxes dormant cancer stem cells to begin differentiating and exit into the blood stream where they can be destroyed by chemotherapy agents.
Comparison of Outcomes of Peripheral and Bone Marrow Stem Cells Transplantation
Bone marrow transplant was first done successfully in 1968. The surgical procedure is required for treating those suffering from leukemia, aplastic anemia, Hodgkin’s disease.
Bone marrow transplant was first done successfully in 1968. The surgical procedure is required for treating those suffering from leukemia, aplastic anemia, Hodgkin’s disease.
Email
